Lipid Triglyceride Surfactant Composition, Patent US12599580B2
Summary
The USPTO granted patent US12599580B2 to BASF AS on April 14, 2026, covering compositions comprising 2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenyloxy)butanoic acid, a triglyceride, and a surfactant, as well as methods of using the same in self-emulsifying drug delivery systems such as SEDDS, SMEDDS, or SNEDDS. The patent contains 20 claims.
What changed
The USPTO issued patent US12599580B2 to BASF AS on April 14, 2026, granting exclusive intellectual property rights to a pharmaceutical composition containing 2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenyloxy)butanoic acid (or ester derivative or salt), a triglyceride, and a surfactant, along with methods of using the composition.
For pharmaceutical manufacturers and drug developers, this patent establishes BASF's proprietary position in self-emulsifying drug delivery system technologies. Competitors seeking to develop similar SEDDS, SMEDDS, or SNEDDS formulations may need to obtain licensing or design around the protected composition claims.
Archived snapshot
Apr 17, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
Grant US12599580B2 Kind: B2 Apr 14, 2026
Assignee
BASF AS
Inventors
Svein Olaf Hustvedt, Preben Houlberg Olesen, Annette Müllertz
Abstract
Compositions comprising 2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenyloxy)butanoic acid, an ester derivative, or a pharmaceutically acceptable salt thereof; a triglyceride; and a surfactant, as well as methods for their use. The present disclosure further relates to self-emulsifying drug delivery systems, such as SEDDS, SMEDDS, or SNEDDS comprising 2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenyloxy)butanoic acid.
CPC Classifications
A61K 31/202
Filing Date
2022-05-05
Application No.
17737761
Claims
20
Related changes
Get daily alerts for USPTO Patent Grants - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.